ClinicalTrials.Veeva

Menu

Safety Study of Continuous Positive Airway Pressure Via a Nasal Mask

Mass General Brigham logo

Mass General Brigham

Status

Completed

Conditions

Upper Airway Obstruction

Treatments

Procedure: nasal mask

Study type

Interventional

Funder types

Other

Identifiers

NCT01524614
2010p002823

Details and patient eligibility

About

Upper airway obstruction (UAO) is common complication during induction of general anesthesia. The mechanism of UAO during anesthesia has not been well understood. Posterior displacement of soft palate are believed to be the primary contributing factors. The mechanism of UAO during anesthesia share many similarities with obstructive sleep apnea (OSA). Since nasal continuous positive airway pressure (nCPAP) can maintain the airway patent in patients with OSA, the investigators hypothesize that nCPAP during induction of anesthesia will reduce the incidence and severity of UAO.

Enrollment

80 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients,between 18-65 years of age meeting ASA physical status classification I-II requiring general anesthesia for elective surgery who are able to breathe through both their nose and mouth while awake.

Exclusion criteria

  1. Patients with major cardiovascular disease, respiratory disease, cerebral vascular disease or American Society of Anesthesiologists physical status class III or greater.
  2. Abnormal vital signs on the day of admission for surgery [heart rate (HR, > 100 bpm or < 40 bpm), blood pressure (BP, > 180/100 mmHg or < 90/60 mmHg), room air transcutaneous oxyhemoglobin saturation (SPO2) < 96%] that are not correctable with his or her routine medication or commonly used pre-operative medication.
  3. Unable to open mouth (< 2.5 cm) or unable to breathe through their mouth or nose.
  4. Subjects with a beard, an abnormal facial structure or other factors precluding obtaining a viable face mask fit without air leak. Also, subjects having claustrophobia that can not tolerate the mask.
  5. Any person with an anticipated difficult airway. This will include subjects who require or may require either a fiberoptic intubation or intubation while awake and subjects with known OSA or body mass index (BMI) greater than 35 km/m2.
  6. Gastric-esophageal reflex or a full stomach.
  7. The subject has remained in bed for more than 24 hours.
  8. Neurological symptoms associated with neck extension, a neurological deficit from a previous stroke or spinal cord injury, a recent stroke or transient ischemic attack (TIA) within 2 weeks.
  9. Pregnant women and women less than one month post-partum. Ruling out pregnancy will be conducted by careful history and physical examination as performed routinely prior to surgery. If the history is believed to be unreliable, the patient will be excluded unless a pregnancy test is performed and the result of the test is negative.
  10. Emergency cases and subjects who have not adhered to the ASA NPO (Nil Per Os) guidelines.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

80 participants in 4 patient groups

Nasal mask with no PEEP
Experimental group
Description:
Nasal mask with PEEP 0, then add PEEP 5, and 10
Treatment:
Procedure: nasal mask
Nasal mask with PEEP
Experimental group
Description:
Nasal mask with PEEP 5, then add PEEP 10
Treatment:
Procedure: nasal mask
Face mask with no PEEP
Experimental group
Description:
Face mask with PEEP 0 then add PEEP 5, 10
Treatment:
Procedure: nasal mask
Face mask with PEEP
Experimental group
Description:
Face mask with PEEP 5, then add PEEP 10
Treatment:
Procedure: nasal mask

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems